Business Standard

Sunday, December 22, 2024 | 07:23 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

SMS Pharma surges 20% on successful inspection of Telangana unit by PMDA

The stock surged 20% to Rs 87.60 on BSE in intra-day trade on back of heavy volumes.

MNCs raise concerns around the definition of inventions, provisions for compulsory licensing
Premium

Some major Western concerns about India’s patent framework are the definitions of inventions and provisions for compulsory licensing

SI Reporter Mumbai
SMS Pharmaceuticals has surged 20% to Rs 87.60 on BSE in intra-day trade after the successful inspection of Telengana plant by Japanese regulator.

The company successfully completed inspection by Pharmaceuticals and Medical Devices Agency (PMDA) Japanese Authorities for the manufacturing facility-Unit II, located in Hyderabad – Telangana.

The inspection was done during the period July 25 – 27. The inspection was focussed on general GMP (Good Manufacturing Practice) inspection of the site. The inspection has been concluded with no critical/major observation.

At 02:52 PM; the stock was up 16% to Rs 84.35 on BSE, as compared to

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in